Art Levin trades the C-suite for pair of roles at Avidity; Ex-Merck CEO Ken Frazier to chair another company
→ Art Levin is calling it a day as CSO of Avidity Biosciences, but he’s not going anywhere: He’s been given …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
